cell-free DNA Science Papers Uncover Protein Involved in Tumor Metastasis, Cancer Detection Via DNA Methylation Sequencing In Science this week: multi-omic approach finds LRG1 is involved in metastasis, and more. Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease A suite of new studies examined how liquid biopsies could personalize treatment strategies in a range of cancer types. Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech Premium Based on promising early results, the company is now conducting a larger case-control study to lock in a classifier for prospective validation in an intended-use population. Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe Premium The move opens the first non-oncology application for Oncocyte, which acquired the relevant cell-free DNA technology in its merger with Chronix this April. Cell-Free DNA Analysis Outperforms Cytology for Leptomeningeal Disease Detection In most cases, cell-free DNA analysis had higher sensitivity and accuracy, suggesting the approach might be better for diagnosing leptomeningeal disease. Jul 1, 2021 BillionToOne Adapting Fetal Dx Tech for Liquid Biopsy, Cancer Therapy Response Monitoring Premium Jun 15, 2021 South Korean Firm EDGC to Expand Reach Into Liquid Biopsy Space With Cell-Free DNA Platform Premium Jun 14, 2021 BillionToOne Raises $55M in Series B Financing May 28, 2021 Tool Detects Pediatric Bone Tumors From Liquid Biopsies Based on Epigenetic Profiles May 2, 2021 Freenome Eyes New Dx Possibilities for Core Technology as CRC Detection Trial Progresses Premium Apr 14, 2021 Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood Premium Apr 7, 2021 OncoDNA, myNEO Partner to Advance Bespoke mRNA-Based Cancer Vaccines Apr 6, 2021 Scottish Liquid Biopsy Startup BioCaptiva Raises £1M in Seed Funding Mar 31, 2021 Delfi Diagnostics Starts Prospective Lung Cancer Screening Trial Mar 25, 2021 Quantgene, CureMatch Partner to Guide Precision Cancer Treatment Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Mar 2, 2021 Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications Mar 1, 2021 TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Jan 11, 2021 Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement Dec 4, 2020 Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents Dec 2, 2020 Judge Denies Natera Motion to Invalidate CareDx, Stanford Patents Nov 20, 2020 Agena Bioscience Shows Off New Liquid Biopsy QC Assay at AMP; Expects January Launch Premium Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 2, 2020 Researchers Turn Methylated DNA Profiling Method Towards Prenatal Testing Applications Premium Load More Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.